Quetiapine treatment for behavioral and psychological symptoms in patients with senile dementia of Alzheimer type

Neuropsychobiology

Volumn 49, Issue 4, 2004, Pages 201-204

  Fujikawa, Tokumi ^a   Takahashi, Terumichi ^a   Kinoshita, Akiko ^a   Kajiyama, Hiroaki ^a   Kurata, Akiko ^a   Yamashita, Hidehisa ^b   Yamawaki, Shigeto ^b  

^a Kamo Psychiatry Medical Center   (Japan)

^b HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Behavioral and psychological symptoms of dementia; Extrapyramidal symptoms; Olanzapine; Quetiapine; Risperidone; Senile dementia of alzheimer type

Indexed keywords

QUETIAPINE;

ADULT; AGED; AGGRESSIVENESS; ALZHEIMER DISEASE; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DELUSIONAL DISORDER; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EVALUATION; EXTRAPYRAMIDAL SYNDROME; FEMALE; HUMAN; MALE; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; RATING SCALE; SAMPLE SIZE; SCORING SYSTEM; SENILE DEMENTIA; TREATMENT INDICATION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIPSYCHOTIC AGENTS; BEHAVIORAL SYMPTOMS; DIBENZOTHIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; EQUIPMENT AND SUPPLIES; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; TREATMENT OUTCOME;

EID: 2342481665     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077367     Document Type: Article

References (25)

1. Devanand DP, Jacobs DM, Tang MX, Del Castillo-Castaneda C, Sano M, Marder K, Bell K, Bylsma FW, Brandt J, Albert M, Stern Y: The course of psychopathologic features in mild to moderate Alzheimer disease. Arch Gen Psychiatry 1997;54:257-263.
2. Rabins PV, Mace NL, Lucas MJ: The impact of dementia on the family. JAMA 1982;248:333-335.
3. Colerick EJ, George LK: Predictors of institutionalization among caregivers of patients with Alzheimer's disease. J Am Geriatr Soc 1986;34:493-498.
4. Steele C, Rovner B, Chase GA, Folstein M: Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. Am J Psychiatry 1990;147:1049-1051.
5. Devanand DP: Antipsychotic treatment in outpatients with dementia. Int Psychogeriatr 1996;8(suppl 3):355-361.
6. Schneider LS: Meta-analysis of controlled pharmacologic trials. Int Psychogeriatr 1996;8:375-379.
7. Finkel SI: Managing the behavioral and psychological signs and symptoms of dementia. Int Clin Psychopharmacol 1997;12(suppl 4):25-28.
8. Glazer WM: Olanzapine and new generation of antipsychotic agents: Patterns of use. J Clin Psychiatry 1997;58 (suppl 10):18-21.
9. Irizarry MC, Ghaemi SN, Lee-Cherry ER, Gomez-Isla T, Binetti G, Hyman BT, Growdon JH: Risperidone treatment of behavioral disturbances in outpatients with dementia. J Neuropsychiatry Clin Neurosci 1999;11:336-342.
10. Katz IR, Jeste DV, Mintzer JE, Clyde C, Napolitano J, Brecher M: Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: A randomized, double-blind trial (Risperidone Study Group). J Clin Psychiatry 1999;60:107-115.
11. Madhusoodanan S, Suresh P, Brenner R, Pillai R: Experience with the atypical antipsychotics: Risperidone and olanzapine in the elderly. Ann Clin Psychiatry 1999;11:113-118.
12. Street JS, Clark WS, Gannon KS, Cummings JL, Bymaster FP, Tamura RN, Mitan SJ, Kadam DL, Sanger TM, Feldman PD, Tollefson GD, Breier A: Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: A double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 2000;57:968-976.
13. Edell WS, Tunis SL: Antipsychotic treatment of behavioral and psychological symptoms of dementia in geropsychiatric inpatients. J Geriatr Psychiatry 2001;9:289-297.
14. Chan W, Lam LC, Choy CN, Leung VP, Li S, Chiu HF: A double-blind randomized comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients. Int J Geriatr Psychiatry 2001;16:1156-1162.
15. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Press, 1994.
16. Kato S, Shimogaki H, Onodera A, Ueda H, Oikawa K, Ikeda K, Kosaka A, Imai Y, Hasegawa K: Development of the revised version of Hasegawa's Dementia Scale (HDS-R) (in Japanese). Jap J Geriatr Psychiatry 1991;2:1339-1347.
17. Folstein MF, Folstein SE, McHugh PR: 'Minimental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
18. Reisberg B, Borenstein J, Salob SP, Ferris SH, Franssen E, Georgotas A: Behavioral symptoms in Alzheimer's disease: Phenomenology and treatment. J Clin Psychiatry 1987;48(suppl):9-15.
19. Cohen-Mansfield J, Billing N: Agitated behaviors in the elderly. 1. A conceptual review. J Am Geriatr Soc 1986;34:711-721.
20. Cohen-Mansfield J: Agitated behaviors in the elderly. 2. Preliminary results in the cognitively deteriorated. J Am Geriatr Soc 1986;34:722-727.
21. Inada T, Yagi G, Miura S: Extrapyramidal symptom profiles in Japanese patients with schizophrenia treated with olanzapine or haloperidol. Schizophr Res 2002;57:227-238.
22. Inada T, Yagi G: Current topics in neuroleptics-induced extrapyramidal symptoms in Japan. Keio J Med 1996;45:95-99.
23. Tandon R, Jibson MD: Efficacy of newer generation antipsychotics in the treatment of schizophrenia. Psychoneuroendocrinology 2003;28(suppl 1):9-26.
24. Leucht S, Pitschel-Walz G, Abraham D, Kissling W: Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials. Schizophr Res 1999;4:51-68.
25. Sajatovic M, Mullen JA, Sweitzer DE: Efficacy of quetiapine and risperidone against depressive symptoms in outpatients with psychosis. J Clin Psychiatry 2002;63:1156-1163.